90 related articles for article (PubMed ID: 30508755)
1. Distribution of platinum between nuclear and cytosolic fractions - Can subcellular fractionation be performed quantitatively?
Dam CS; Lambert IH; Gammelgaard B; Stürup S
J Pharm Biomed Anal; 2019 Feb; 165():82-89. PubMed ID: 30508755
[TBL] [Abstract][Full Text] [Related]
2. Binding of cis-dichlorodiammine platinum(II) to metallothionein in Ehrlich cells.
Kraker A; Schmidt J; Krezoski S; Petering DH
Biochem Biophys Res Commun; 1985 Jul; 130(2):786-92. PubMed ID: 4040756
[TBL] [Abstract][Full Text] [Related]
3. New application of a subcellular fractionation method to kidney and testis for the determination of conjugated linoleic acid in selected cell organelles of healthy and cancerous human tissues.
Hoffmann K; Blaudszun J; Brunken C; Höpker WW; Tauber R; Steinhart H
Anal Bioanal Chem; 2005 Mar; 381(6):1138-44. PubMed ID: 15761741
[TBL] [Abstract][Full Text] [Related]
4. Quantitative subcellular distribution of platinum in rat tissues following i.v. bolus and i.v. infusion of cisplatin.
Parti R; Wolf W
Cancer Chemother Pharmacol; 1990; 26(3):188-92. PubMed ID: 2357765
[TBL] [Abstract][Full Text] [Related]
5. Determination of platinum in human subcellular microsamples by inductively coupled plasma mass spectrometry.
Björn E; Nygren Y; Nguyen TT; Ericson C; Nöjd M; Naredi P
Anal Biochem; 2007 Apr; 363(1):135-42. PubMed ID: 17286953
[TBL] [Abstract][Full Text] [Related]
6. Characterization and significance of carbamyl phosphate phosphatase.
Black MJ; Jones ME
Cancer Res; 1984 Oct; 44(10):4366-76. PubMed ID: 6088037
[TBL] [Abstract][Full Text] [Related]
7. Combining TBP-based rOFFGEL-IEF with FASP and nLC-ESI-LTQ-MS/MS for the analysis of cisplatin-binding proteins in rat kidney.
Moraleja I; Moreno-Gordaliza E; Mena ML; Gómez-Gómez MM
Talanta; 2014 Mar; 120():433-42. PubMed ID: 24468393
[TBL] [Abstract][Full Text] [Related]
8. Differences in cisplatin distribution in sensitive and resistant ovarian cancer cells: a TEM/NanoSIMS study.
Lee RFS; Riedel T; Escrig S; Maclachlan C; Knott GW; Davey CA; Johnsson K; Meibom A; Dyson PJ
Metallomics; 2017 Oct; 9(10):1413-1420. PubMed ID: 28913538
[TBL] [Abstract][Full Text] [Related]
9. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
[TBL] [Abstract][Full Text] [Related]
10. Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin.
Groessl M; Zava O; Dyson PJ
Metallomics; 2011 Jun; 3(6):591-9. PubMed ID: 21399784
[TBL] [Abstract][Full Text] [Related]
11. Subcellular localization of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells.
Londos-Gagliardi D; Aubel-Sadron G; Maral R; Trouet A
Eur J Cancer (1965); 1980 Jun; 16(6):849-54. PubMed ID: 7408932
[No Abstract] [Full Text] [Related]
12. In vitro studies on cisplatin focusing on kinetic aspects of intracellular chemistry by LC-ICP-MS.
Hermann G; Heffeter P; Falta T; Berger W; Hann S; Koellensperger G
Metallomics; 2013 Jun; 5(6):636-47. PubMed ID: 23487031
[TBL] [Abstract][Full Text] [Related]
13. cis-Platinum: subcellular distribution and binding to cytosolic ligands.
Sharma RP; Edwards IR
Biochem Pharmacol; 1983 Sep; 32(18):2665-9. PubMed ID: 6313005
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of Gd@C82(OH)22 and cisplatin uptake in single cells by inductively coupled plasma mass spectrometry.
Zheng LN; Wang M; Zhao LC; Sun BY; Wang B; Chen HQ; Zhao YL; Chai ZF; Feng WY
Anal Bioanal Chem; 2015 Mar; 407(9):2383-91. PubMed ID: 25701412
[TBL] [Abstract][Full Text] [Related]
15. One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.
Yamada K; Kato N; Takagi A; Koi M; Hemmi H
Anal Bioanal Chem; 2005 Aug; 382(7):1702-7. PubMed ID: 15959768
[TBL] [Abstract][Full Text] [Related]
16. Detection of platinum in the brain of mice treated with cisplatin and subjected to short-term hypoxia.
Minami T; Ichii M; Okazaki Y
J Pharm Pharmacol; 1996 May; 48(5):505-9. PubMed ID: 8799875
[TBL] [Abstract][Full Text] [Related]
17. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
[TBL] [Abstract][Full Text] [Related]
18. Gel electrophoresis in combination with laser ablation-inductively coupled plasma mass spectrometry to quantify the interaction of cisplatin with human serum albumin.
Sullivan MP; Morrow SJ; Goldstone DC; Hartinger CG
Electrophoresis; 2019 Sep; 40(18-19):2329-2335. PubMed ID: 31087392
[TBL] [Abstract][Full Text] [Related]
19. Quantitative imaging of platinum based on laser ablation-inductively coupled plasma-mass spectrometry to investigate toxic side effects of cisplatin.
Köppen C; Reifschneider O; Castanheira I; Sperling M; Karst U; Ciarimboli G
Metallomics; 2015 Dec; 7(12):1595-603. PubMed ID: 26477751
[TBL] [Abstract][Full Text] [Related]
20. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
